We are live on
!
Find out more
Pzena Investment Management Portfolio holdings
AUM
$30.8B
1-Year Est. Return
11.29%
This Fund
S&P 500
This Quarter
Est. Return
+3.75%
1 Year Est. Return
+11.29%
3 Year Est. Return
+35.84%
5 Year Est. Return
+55.56%
10 Year Est. Return
+196.8%
AUM
$26.5B
AUM Growth
-$77.5M
(-0.29%)
Cap. Flow
-$478M
Cap. Flow
% of AUM
-1.81%
Top 10 Holdings %
Top 10 Hldgs %
35.58%
Holding
192
New
18
Increased
78
Reduced
54
Closed
15
Top Buys
| 1 |
Newell Brands
NWL
|
+$183M |
| 2 |
Lear
LEA
|
+$179M |
| 3 |
Shell
SHEL
|
+$175M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$166M |
| 5 |
SS&C Technologies
SSNC
|
+$156M |
Top Sells
| 1 |
Halliburton
HAL
|
+$513M |
| 2 |
Baker Hughes
BKR
|
+$322M |
| 3 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$174M |
| 4 |
Cenovus Energy
CVE
|
+$123M |
| 5 |
Textron
TXT
|
+$115M |
Sector Composition
| 1 | Financials | 26.19% |
| 2 | Technology | 15.36% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Industrials | 11.52% |
| 5 | Energy | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Meta Platforms (Facebook)
META
$1.67T
| $646K | ﹤0.01% |
2,903
+1,565
| +117% | +$391K |
|
127
Regeneron Pharmaceuticals
REGN
$69.5B
| $645K | ﹤0.01% |
924
+20
| +2% | +$12.7K |
|
128
Halozyme
HALO
$9.03B
| $628K | ﹤0.01% |
+15,738
| New | +$561K |
|
129
Ituran Location and Control
ITRN
$1.1B
| $626K | ﹤0.01% |
27,215
+2,209
| +9% | +$51.4K |
|
130
Nokia
NOK
$65.3B
| $611K | ﹤0.01% |
111,936
+17,670
| +19% | +$97.9K |
|
131
Intel
INTC
$518B
| $527K | ﹤0.01% |
10,632
+2,704
| +34% | +$134K |
|
132
Qorvo
QRVO
$7.44B
| $527K | ﹤0.01% |
4,245
+2,657
| +167% | +$360K |
|
133
Biogen
BIIB
$30.9B
| $502K | ﹤0.01% |
+2,384
| New | +$518K |
|
134
United Therapeutics
UTHR
$22.7B
| $497K | ﹤0.01% |
2,768
+181
| +7% | +$34.5K |
|
135
Expeditors International
EXPD
$23B
| $490K | ﹤0.01% |
4,746
+3,050
| +180% | +$336K |
|
136
Williams-Sonoma
WSM
$25.5B
| $482K | ﹤0.01% |
+6,654
| New | +$504K |
|
137
Cencora
COR
$59.6B
| $476K | ﹤0.01% |
3,079
-1,554
| -34% | -$220K |
|
138
Lam Research
LRCX
$413B
| $473K | ﹤0.01% |
8,790
+2,120
| +32% | +$123K |
|
139
Exelixis
EXEL
$14.1B
| $469K | ﹤0.01% |
+20,669
| New | +$404K |
|
140
IPG Photonics
IPGP
$4.45B
| $460K | ﹤0.01% |
+4,192
| New | +$576K |
|
141
Playtika
PLTK
$1.56B
| $441K | ﹤0.01% |
+22,824
| New | +$406K |
|
142
Barclays
BCS
$92B
| $437K | ﹤0.01% |
55,321
| – | – |
|
143
Skyworks Solutions
SWKS
$8.76B
| $428K | ﹤0.01% |
+3,209
| New | +$450K |
|
144
Merck
MRK
$306B
| $418K | ﹤0.01% |
5,092
-1,793
| -26% | -$141K |
|
145
Yeti Holdings
YETI
$3.66B
| $404K | ﹤0.01% |
+6,729
| New | +$434K |
|
146
Dell
DELL
$276B
| $382K | ﹤0.01% |
7,618
| – | – |
|
147
Humana
HUM
$48.7B
| $367K | ﹤0.01% |
844
| – | – |
|
148
Maximus
MMS
$3.07B
| $349K | ﹤0.01% |
4,657
+24
| +0.5% | +$1.84K |
|
149
D.R. Horton
DHI
$42.2B
| $297K | ﹤0.01% |
+3,981
| New | +$345K |
|
150
C.H. Robinson
CHRW
$23.2B
| $277K | ﹤0.01% |
2,572
-1,816
| -41% | -$184K |
|
Similar funds
